Status:
COMPLETED
Hydrating Efficacy and Tolerance Evaluation of a Face Cream
Lead Sponsor:
Derming SRL
Conditions:
Dry and Damaged Skin
Eligibility:
All Genders
45-60 years
Phase:
NA
Brief Summary
Aim of the study was to evaluate by non-invasive instrumental evaluations tolerance and hydrating activity of a face topic product, to be applied twice a day, morning and evening, for an uninterrupted...
Eligibility Criteria
Inclusion
- both sexes,
- age 45-60 years,
- caucasian subjects,
- agreeing to present at each study visit without make-up,
- accepting to follow the instructions received by the investigator,
- accepting to not change their habits regarding food, physical activity, face cleansing and make- up use,
- agreeing not to apply or take any product or use face massages or other means known to improve skin wrinkle and skin qualities during the entire duration of the study,
- accepting not to expose their face to strong UV irradiation (UV session, or sun bathes), during the entire duration of the study,
- no participation in a similar study currently or during the previous 3 months
- accepting to sign the Informed consent form.
Exclusion
- Pregnancy (only for female subjects),
- lactation (only for female subjects),
- sensitivity to the test product or its ingredients (to be assessed by the investigator during the baseline visit),
- subjects whose insufficient adhesion to the study protocol is foreseeable.
- presence of cutaneous disease on the tested area as lesions, scars, malformations,
- recurrent facial/labial herpes,
- clinical and significant skin condition on the test area (e.g. active eczema, dermatitis, psoriasis etc.).
- endocrine disease,
- hepatic disorder,
- renal disorder,
- cardiac disorder,
- pulmonary disease,
- cancer,
- neurological or psychological disease,
- inflammatory/immunosuppressive disease,
- drug allergy.
- anti-inflammatory drugs, anti-histaminic, topic (application on the face) and systemic corticosteroids, narcotic, antidepressant, immunosuppressive drugs (with the except of hormonal treatment starting more than 1 year ago),
- using of drugs or dietary supplements able to influence the test results in the investigator opinion.
Key Trial Info
Start Date :
March 22 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 25 2017
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT03279159
Start Date
March 22 2017
End Date
May 25 2017
Last Update
September 12 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
DERMING
Monza, Monza-brianza, Italy, 20900